Lisdexamfetamine Dimesylate Tablet, Chewable — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Tablet, Chewable (tablet, chewable) from Takeda Pharmaceuticals USA Inc. with status Current. The shortage was first posted on 07/14/2023.
Shortage Details
- Status
- Current
- Company
- Takeda Pharmaceuticals USA Inc.
- Package NDC
- 59417-118-01
- Dosage Form
- Tablet, Chewable
- Presentation
- Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)
- Initial Posting
- 07/14/2023
- Revised Date